Pracinostat - CAS 929016-96-6

Pracinostat (SB939) is a novel HDAC inhibitor with improved in vivo properties compared to other HDAC inhibitors currently in Clinicalal trials, allowing oral dosing. Data demonstrate that Pracinostat is a potent and effective anti-tumor drug with potential as an oral therapy for a variety of human hematological and solid tumors.

Apoptosis, Antibacterial, HDAC

Microbiology/Virology, DNA Damage/DNA Repair, Apoptosis, Chromatin/Epigenetic

928914

0.9967

C20H30N4O2

358.48

CCCCc1nc2cc(\C=C\C(=O)NO)ccc2n1CCN(CC)CC

-20°C

Ice Packs

Small Compound